百奧賽圖邀您參加2018年瑞士日內瓦免疫腫瘤學大會（ESMO IO Congress 2018）

  本次大會旨在與各領域專家學者共同探討免疫治療的基礎知識以及最新的研究成果，有助于全面了解免疫治療的潛力及其對臨床實踐的影響，探討不同的治療方案，更好的服務于腫瘤患者。

  百奧賽圖榮幸受邀參展此次大會，且在4篇被選中的摘要中有兩篇獲得2018 ESMO IO Congress Merit Award（詳見下文）。百奧賽圖將在此次大會中設置展臺（#4）,歡迎您前來交流！

會議信息

時間：2018年12月13日至12月16日

地點：瑞士日內瓦Palexpo exhibition centre

展臺：#4

海報展區：Foyer，Geneva Palexpo

日程：請點擊文末鏈接

The Congress keeps oncologists up-to-date in this rapidly evolving field and is the ideal platform for all interested stakeholders. From the basics of immunotherapies to the latest research results; from understanding different treatment options to management of toxicities and interpretation of new data, the Congress builds the European community of immuno-oncology stakeholders

We are very proud that four poster presentations from Biocytogen has been selected and will be presented at this event.

We are looking forward to meeting you at our booth (#4)! We are glad to have the opportunity to share our expertise with conference attendees on: 

1) generating customized gene-targeted animal models and cell lines

2) providing immune checkpoint humanized mouse models for antibody drug efficacy studies 

3) constructing human immune system reconstituted B-NDG mouse model for I/O studies 

4)  performing pharmacological studies based on our unique mouse models

5)  providing antibody R&D services

日程鏈接：https://www.esmo.org/Conferences/ESMO-Immuno-Oncology-Congress-2018

掃碼關注百奧賽圖了解更多咨詢哦